Schonfeld Strategic Advisors LLC Precision Biosciences Inc Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.7 - $1.41 $13,790 - $27,777	-19,700 Reduced 65.67%	10,300 $7,000
Q4 2022 Feb 14, 2023	SELL	$0.97 - $45.0 $33,465 - $1.55 Million	-34,500 Reduced 53.49%	30,000 $35,000
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $16,185 - $541,293	-13,267 Reduced 17.06%	64,500 $83,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $15,142 - $43,977	13,167 Added 20.38%	77,767 $124,000
Q1 2022 May 16, 2022	BUY	$2.96 - $7.76 $191,216 - $501,296	64,600 New	64,600 $199,000
Q3 2021 Nov 16, 2021	SELL	$9.18 - $14.15 $325,779 - $502,155	-35,488 Closed	0 $0
Q2 2021 Nov 16, 2021	SELL	$8.07 - $12.52 $58,911 - $91,396	-7,300 Reduced 17.06%	35,488 $444,000
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $217,760 - $337,839	26,984 Added 170.74%	42,788 $535,000
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $135,440 - $249,545	15,804 New	15,804 $164,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.